An International business professional in Pharmaceutical Industry, who was working currently in Shanghai CP Guojian Pharmaceutical Co., Ltd. as a Regional Manager responbisle for business development in EU and MENA area.CPGJ is a leading bio-pharmaceutical high-tech company in China which is focused on the R&D, pilot development, industrialization and commercialization of monoclonal antibody drugs. CPGJ is the first company in the world which launched the Biosimilar Etanercept for Rheumatoid Arthritis in the Global market as early as in 2006. Currently, CPGJ has several MaB's scheduled for launching with two Biosimilars are already launched in the market.With 8 years international business experience including 6 years in Pharmaceutical industry, Andy is especially good at souring and marketing, seeking potential business oppotunities, setting up partnership with foreign clients, leading both sides into the pharmaceutical markets of each other's, passing through Regulatory Affairs, and finally launching and marketing products.Andy is keen on connecting with professionals worldwide who are in the Pharmaceutical Industry to share pharmaceutical industry knowledge, also to explore potential business development opportunities for Biosimilar products.